33X-23005-44219
1 vaccination
1 coded response
2 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 460 / IN
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-16
Dose 1 — Pfizer-BioNTech
-
2021-03-08
Registered in v-safe
- 2021-03-08
-
2021-05-18
Survey response — 3 months, dose 1MedDRA: Cough, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Be unable to work, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Congestion, runny nose, and coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-18
Report sent to call center — 3 months, dose 1Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-16 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-18 | Unsuccessful |
Free text
Release 8 — 3 months, dose 1
Symptoms: Congestion, runny nose, and cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release